K
Keith M. Sullivan
Researcher at Duke University
Publications - 458
Citations - 40788
Keith M. Sullivan is an academic researcher from Duke University. The author has contributed to research in topics: Transplantation & Total body irradiation. The author has an hindex of 105, co-authored 447 publications receiving 39067 citations. Previous affiliations of Keith M. Sullivan include American Cancer Society & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.
Frederick R. Appelbaum,Janet Barrall,Rainer Storb,LD Fisher,Gary Schoch,R E Ramberg,Howard M. Shulman,Claudio Anasetti,Scott I. Bearman,Patrick G. Beatty,William I. Bensinger,C. Dean Buckner,Reginald A. Clift,John A. Hansen,Paul J. Martin,Finn Bo Petersen,Jean E. Sanders,J. W. Singer,Patricia S. Stewart,Keith M. Sullivan,Robert P. Witherspoon,E. Donnall Thomas +21 more
TL;DR: Bone marrow transplantation offers a potential cure for many patients with myelodysplasia and best results can be expected in younger patients who receive transplants relatively early in their disease course.
Journal Article
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
Keith M. Sullivan,Jan Storek,Kenneth J. Kopecky,Jane Jocom,Gary Longton,Mary E.D. Flowers,M. Siadak,J. Nims,Robert P. Witherspoon,Claudio Anasetti,F R Appelbaum,Raleigh A. Bowden,C. D. Buckner,Stephen W. Crawford,Deeg Hj,J.A. Hansen,George B. McDonald,Jean E. Sanders,R Storb +18 more
TL;DR: It is concluded that in the absence of hypogammaglobulinemia, monthly administration of IVIg given from day 90 to 360 does not reduce late complications and may impair long-term humoral immune recovery after marrow transplantation.
Journal ArticleDOI
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
Scott I. Bearman,FR Appelbaum,Anthony L. Back,Finn Bo Petersen,Buckner Cd,Keith M. Sullivan,H G Schoch,LD Fisher,Thomas Ed +8 more
TL;DR: Severe or fatal toxicities directly related to the preparative regimen are a significant problem in the treatment of patients with advanced malignant lymphoma and can be reduced by carrying out transplantation earlier in the course of the disease.
Journal ArticleDOI
Esophageal abnormalities in chronic graft-versus-host disease in humans
George B. McDonald,Keith M. Sullivan,Michael D. Schuffler,Howard M. Shulman,E. Donnall Thomas +4 more
TL;DR: It is concluded that esophageal epithelium, like skin and mucous membranes, is a target organ in chronic graft-versus-host disease and results in desquamative esophagitis with web formation.